Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 3/2012

Ausgabe 3/2012

Inhaltsverzeichnis ( 35 Artikel )

01.12.2012 | Review | Ausgabe 3/2012

The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions

Suzanne B. Coopey, Emanuele Mazzola, Julliette M. Buckley, John Sharko, Ahmet K. Belli, Elizabeth M. H. Kim, Fernanda Polubriaginof, Giovanni Parmigiani, Judy E. Garber, Barbara L. Smith, Michele A. Gadd, Michelle C. Specht, Anthony J. Guidi, Constance A. Roche, Kevin S. Hughes

01.12.2012 | Review | Ausgabe 3/2012

Use of antidepressants and the risk of breast cancer: a meta-analysis

Chun-Sick Eom, Sang Min Park, Kyung-Hwan Cho

01.12.2012 | Preclinical Study | Ausgabe 3/2012

Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer

Ana Rocha, Lei Wang, Manuel Penichet, Manuela Martins-Green

01.12.2012 | Preclinical Study | Ausgabe 3/2012

IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients

María P. Roberti, Yamila S. Rocca, Mora Amat, María B. Pampena, José Loza, Federico Coló, Verónica Fabiano, Carlos M. Loza, Juan M. Arriaga, Michele Bianchini, María M. Barrio, Alicia I. Bravo, Enzo Domenichini, Reinaldo Chacón, José Mordoh, Estrella M. Levy

01.12.2012 | Preclinical Study | Ausgabe 3/2012

Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models

Yesim Gökmen-Polar, Yi Liu, Rachel A. Toroni, Kerry L. Sanders, Rutika Mehta, Sunil Badve, Christian Rommel, George W. Sledge Jr.

01.12.2012 | Preclinical Study | Ausgabe 3/2012

PI3K independent activation of mTORC1 as a target in lapatinib-resistant ERBB2+ breast cancer cells

Anna-Maria Jegg, Toby M. Ward, Elizabeth Iorns, Nicholas Hoe, JinYao Zhou, Xiaofei Liu, Sharat Singh, Ralf Landgraf, Mark D. Pegram

01.12.2012 | Preclinical Study | Ausgabe 3/2012 Open Access

Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells?

Anguraj Sadanandam, Aseem Lal, Stephen C. Benz, Serenella Eppenberger-Castori, Gary Scott, Joe W. Gray, Paul Spellman, Fred Waldman, Christopher C. Benz

01.12.2012 | Preclinical study | Ausgabe 3/2012

Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer

Anoek H. J. Verschuur-Maes, Peter C. de Bruin, Paul J. van Diest

01.12.2012 | Preclinical study | Ausgabe 3/2012

Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours

Brigid C. Browne, Alex J. Eustace, Susan Kennedy, Neil A. O’Brien, Kasper Pedersen, Martina S. J. McDermott, Annemarie Larkin, Jo Ballot, Thamir Mahgoub, Francesco Sclafani, Stephen Madden, John Kennedy, Michael J. Duffy, John Crown, Norma O’Donovan

01.12.2012 | Preclinical Study | Ausgabe 3/2012

Alcohol consumption suppresses mammary tumor metastasis in a syngeneic tumor transplantation model

Beth A. Vorderstrasse, Tao Wang, Annette K. Myers, Katherine L. Wyrick, Gary G. Meadows

01.12.2012 | Preclinical Study | Ausgabe 3/2012

Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells

Chi Zhang, Xuening Duan, Ling Xu, Jingming Ye, Jianxin Zhao, Yinhua Liu

01.12.2012 | Clinical Trial | Ausgabe 3/2012

Knowledge and perceptions of familial and genetic risks for breast cancer risk in adolescent girls

Angela R. Bradbury, Linda Patrick-Miller, Brian L. Egleston, Lisa A. Schwartz, Colleen B. Sands, Rebecca Shorter, Cynthia W. Moore, Lisa Tuchman, Paula Rauch, Shreya Malhotra, Brianne Rowan, Stephanie Van Decker, Helen Schmidheiser, Lisa Bealin, Patrick Sicilia, Mary B. Daly

01.12.2012 | Clinical Trial | Ausgabe 3/2012

Phase II open-label study of sunitinib in patients with advanced breast cancer

Denise A. Yardley, E. Claire Dees, Stephen D. Myers, Sherry Li, Paul Healey, Zhixiao Wang, Marla J. Brickman, Jolanda Paolini, Kenneth A. Kern, Dennis L. Citrin

01.12.2012 | Clinical Trial | Ausgabe 3/2012

Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study

Kishor M. Wasan, Paul E. Goss, P. Haydn Pritchard, Lois Shepherd, Dongsheng Tu, James N. Ingle

01.12.2012 | Clinical trial | Ausgabe 3/2012

Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer

Joanne L. Blum, Carlos H. Barrios, Nancy Feldman, Sunil Verma, Edward F. McKenna, Luen F. Lee, Nana Scotto, Julie Gralow

01.12.2012 | Clinical trial | Ausgabe 3/2012

Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer

C. F. Jehn, B. Flath, A. Strux, M. Krebs, K. Possinger, A. Pezzutto, D. Lüftner

01.12.2012 | Clinical trial | Ausgabe 3/2012

Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up

L. Malorni, P. B. Shetty, C. De Angelis, S. Hilsenbeck, M. F. Rimawi, R. Elledge, C. K. Osborne, S. De Placido, G. Arpino

01.12.2012 | Epidemiology | Ausgabe 3/2012

Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses’ Health Studies

Megan S. Rice, Shelley S. Tworoger, Bernard A. Rosner, Michael N. Pollak, Susan E. Hankinson, Rulla M. Tamimi

01.12.2012 | Epidemiology | Ausgabe 3/2012

Time to diagnosis and breast cancer stage by race/ethnicity

Erica T. Warner, Rulla M. Tamimi, Melissa E. Hughes, Rebecca A. Ottesen, Yu-Ning Wong, Stephen B. Edge, Richard L. Theriault, Douglas W. Blayney, Joyce C. Niland, Eric P. Winer, Jane C. Weeks, Ann H. Partridge

01.12.2012 | Epidemiology | Ausgabe 3/2012 Open Access

Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality

Yaojen Chang, Clyde B. Schechter, Nicolien T. van Ravesteyn, Aimee M. Near, Eveline A. M. Heijnsdijk, Lucile Adams-Campbell, David Levy, Harry J. de Koning, Jeanne S. Mandelblatt

01.12.2012 | Epidemiology | Ausgabe 3/2012

Plasma matrix metalloproteinases and postmenopausal breast cancer risk: a nested case–control study in the Multiethnic Cohort study

Yeonju Kim, Nicholas J. Ollberding, Yurii B. Shvetsov, Adrian A. Franke, Lynne R. Wilkens, Gertraud Maskarinec, Brenda Y. Hernandez, Loïc Le Marchand, Brian E. Henderson, Laurence N. Kolonel, Marc T. Goodman

01.12.2012 | Epidemiology | Ausgabe 3/2012

The SLC4A7 variant rs4973768 is associated with breast cancer risk: evidence from a case–control study and a meta-analysis

Wei Chen, Rong Zhong, Jie Ming, Li Zou, Beibei Zhu, Xuzai Lu, Juntao Ke, Yu Zhang, Li Liu, Xiaoping Miao, Tao Huang

01.12.2012 | Epidemiology | Ausgabe 3/2012

Pattern of follow-up care and early relapse detection in breast cancer patients

Sandra M. E. Geurts, Femmie de Vegt, Sabine Siesling, Karin Flobbe, Katja K. H. Aben, Margriet van der Heiden-van der Loo, André L. M. Verbeek, Jos A. A. M. van Dijck, Vivianne C. G. Tjan-Heijnen

01.12.2012 | Epidemiology | Ausgabe 3/2012

Germline mutations in RAD51C in Jewish high cancer risk families

Anya Kushnir, Yael Laitman, Shani Paluch Shimon, Raanan Berger, Eitan Friedman

01.12.2012 | Epidemiology | Ausgabe 3/2012

Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer

Lingeng Lu, Guangjian Zhu, Chong Zhang, Qian Deng, Dionyssios Katsaros, Susan T. Mayne, Harvey A. Risch, Lina Mu, Emilie Marion Canuto, Gianluca Gregori, Chiara Benedetto, Herbert Yu

01.12.2012 | Epidemiology | Ausgabe 3/2012

Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis

Liping Zhou, Fan Yao, Hong Luan, Yinling Wang, Xihua Dong, Wenwen Zhou, Qihui Wang

01.12.2012 | Epidemiology | Ausgabe 3/2012

Patients’ willingness to participate in a breast cancer biobank at screening mammogram

Christoph I. Lee, Lawrence W. Bassett, Mei Leng, Sally L. Maliski, Bryan B. Pezeshki, Colin J. Wells, Carol M. Mangione, Arash Naeim

01.12.2012 | Brief Report | Ausgabe 3/2012 Open Access

The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer

Mohammad R. Akbari, Wojciech Kluźniak, Rachelle Rodin, Song Li, Dominika Wokołorczyk, Robert Royer, Aniruddh Kashyap, Janusz Menkiszak, Jan Lubinski, Steven A. Narod, Cezary Cybulski

01.12.2012 | Brief Report | Ausgabe 3/2012

The clinical consequences of hemizygosity across 2 MB of 10q23 are restricted to Cowden syndrome

Cheryl M. Lewis, Dawei Bu, Venetia Sarode, Linda Robinson, Kathleen S. Wilson, Rebecca K. Viscusi, Charis Eng, David M. Euhus

01.12.2012 | Brief Report | Ausgabe 3/2012

Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference

Masakazu Toi, John R. Benson, Eric P. Winer, John F. Forbes, Gunter von Minckwitz, Mehra Golshan, John F. R. Robertson, Hironobu Sasano, Bernard F. Cole, Louis W. C. Chow, Mark D. Pegram, Wonshik Han, Chiun-Sheng Huang, Tadashi Ikeda, Shotaro Kanao, Eun-Sook Lee, Shinzaburo Noguchi, Shinji Ohno, Ann H. Partridge, Roman Rouzier, Mitsuhiro Tozaki, Tomoharu Sugie, Akira Yamauchi, Takashi Inamoto

01.12.2012 | Letter to the Editor | Ausgabe 3/2012

Comment on prognostic and therapeutic implications of mTORC2 and rictor expression in human breast cancer

U. Wazir, R. F. Newbold, W. G. Jiang, A. K. Sharma, K. Mokbel

01.12.2012 | Letter to the Editor | Ausgabe 3/2012 Open Access

Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients

Ava Kwong, Enders K. O. Ng, Fian B. F. Law, H. N. Wong, Anna Wa, Chris L. P. Wong, Allison W. Kurian, Dee W. West, James M. Ford, Edmond S. K. Ma

01.12.2012 | Erratum | Ausgabe 3/2012

Erratum to: Women’s features and inter-/intra-rater agreement on mammographic density assessment in full-field digital mammograms (DDM-SPAIN)

Beatriz Pérez-Gómez, Franciso Ruiz, Inmaculada Martínez, María Casals, Josefa Miranda, Carmen Sánchez-Contador, Carmen Vidal, Rafael Llobet, Marina Pollán, Dolores Salas

01.12.2012 | Erratum | Ausgabe 3/2012

Erratum to: Effect of a mixed solution of sodium hyaluronate and carboxymethyl cellulose on upper limb dysfunction after total mastectomy: a double-blind, randomized clinical trial

Eun Joo Yang, Eunyoung Kang, Jin Youn Jang, Dongwon Kim, Cha Kyong Yom, Jae-Young Lim, Sung-Won Kim

01.12.2012 | Ausgabe 3/2012

Acknowledgement of reviewers 2011

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise